Sunny Tam, PhD has 25 years of biotechnology and academic experiences in early stage R&D, preclinical testing, assay and technology development following his training from the Boston University School of Medicine and Harvard University School of Public Health. He has held numerous scientific and senior management positions in small molecule discovery and protein therapeutic companies such as TBC, Tanox Inc. and Charles River Laboratories. Dr. Tam is a pioneer in protein microarray development and application of proteomic tools in drug discovery, biomarker discovery and assay development. He is well published and has contributed significantly toward a number of issued patents and federally awarded grants. During his tenure as the Program Director and Research Associate Professor at the University of Massachusetts Medical School, Dr. Tam had successfully established instructional programs in the training of Postdoctoral fellows, PhD/MD & PhD students, and local undergraduate student interns. While serving as a research faculty member at Clark University, he again had created a state of art GLP Proteomics and Metabolomics laboratory in the training of graduate and undergraduate students. More recently, Dr. Tam is leading a graduate Biotechnology department at Framingham State University in organizing faculty members and training students in the technical, regulatory and managerial roles of the fast expanding biopharmaceutical industry.